Parkman Healthcare Partners’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Parkman Healthcare Partners’s Portfolio ASLN Stock Details ASLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-13,832	Closed	-$57.8K	–	115
2023 Q4	$57.8K	Sell	13,832 -32,761	-70%	-$247K	0.01%	89
2023 Q3	$701K	Sell	46,593 -16,735	-26%	-$307K	0.13%	96
2023 Q2	$1.85M	Buy	+63,328	New	+$1.96M	0.32%	78
2021 Q3	–	Sell	-5,647	Closed	-$745K	–	85
2021 Q2	$745K	Sell	5,647 -2,478	-30%	-$310K	0.16%	76
2021 Q1	$1.09M	Buy	+8,125	New	+$1.03M	0.25%	73

Other funds holding ASLN

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Parkman Healthcare Partners's ASLN Position: Q1 2024 in Review

Parkman Healthcare Partners sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q1 2024, closing a stake of 13,832 shares — an estimated $57.8K sold.

Parkman Healthcare Partners first reported a position in ASLN in Q1 2021 and held it in 5 quarters. The position peaked at $1.85M in Q2 2023. 22 funds tracked by Wall St. Rank hold ASLN as of Q1 2024.

Parkman Healthcare Partners reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Parkman Healthcare Partners sold 13,832 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q1 2024, an estimated $57.8K.
Parkman Healthcare Partners first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q1 2021 and held it in 5 quarters.
Parkman Healthcare Partners's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $1.85M in Q2 2023.
22 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q1 2024.

Based on Parkman Healthcare Partners's 13F filing for Q1 2024, filed 15 May 2024.